New & Investigational Drugs
The US Food & Drug Administration oversees and certifies trials of new drugs to treat disease or otherwise
improve health. New drugs are always being introduced, while many others may be investigated but never come to
market. Oftentimes patients may be interested in participating in clinical trials of new and investigational medications,
particularly for rare diseases or those for which a standard treatment is not available or has not proved efficaceous.
Online Resources
Inteleos UNC Access ONLY
The NDA Pipeline tracks drug and biological product approvals. It includes a comprehensive listing of
drugs in research, descriptions of phases of development, and licensing information. The NDA Pipeline
also links to other publications from the FDC Reports.
Centerwatch Drug Directories
Linked from this page are several drug guides, including a listing of drugs recently approved by the FDA, a database of results of
recently completed and ongoing clinical trials, and drugs currently being researched in trials.
Questions and Answers about
Investigational Drugs
On the non-profit Patient Advocate Foundation website, this tutorial answers many questions on the
process of drug approval. It is rewritten from the original NCI list, and supplies the reader with a common
language description of the process. There is information for the consumer on how to get investigational drugs
and warning associeated with them This also includes links to cancer trials websites, investigational drug resources,
and other related sites.
New Medicines in Development Database
Provided by the Pharmaceutical Research and Manufacturers of America, this
database contains information on pharmaceutical products in the research and testing
phase. Information has been obtained through government and industry sources based upon
the latest information but may not be comprehensive. The database can be searched by
disease, indication or drug.
NCI Investigational Drugs -
Status of Compounds
Designed to provide those involved in various phases of drug development
with chemical and physical data on compounds which are past or current
development candidates in the Developmental Therapeutics Program, Division
of Cancer Treatment Diagnosis and Centers, National Cancer Institute. These
range from agents which have only just entered the development pipeline to
those which are available commercially.
Doctor's Guide - Recently Approved Drugs/Indications
Links to Internet news reports relating to the approval of new drugs or of new indications for
previously available drugs, both domestic and international.
ClinicalTrials.gov
This site is part of the National Library of Medicine and is a service of the
National Institutes of Health. It links users with over 7,200 clinical studies worldwide in a variety of
medial specialties. Studies can be identified by condition/disease, drug, sponsor, location, and a number of other factors.
|
